VCEL
Vericel Corp
Key Financials
Gross Profit
$205.6M
↑ 19.5%
Operating Income
$11.0M
↑ 144.4%
EPS (Diluted)
$0.32
↑ 60.0%
Total Liabilities
$133.3M
↓ 5.3%
Total Assets
$488.0M
↑ 12.8%
Shareholders' Equity
$354.6M
↑ 21.5%
Cash & Equivalents
$100.1M
↑ 34.3%
Long-term Debt
$6000.00
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 144 | 6/26/2026 | View on SEC |
| 144 | 6/26/2026 | View on SEC |
| 144 | 6/26/2026 | View on SEC |
| 144 | 6/26/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VCEL |
| Company Name | Vericel Corp |
| CIK | 887359 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MI |
| Phone | 6175885555 |